Background There is still no reliable biomarker for the diagnosis of pancreatic
adenocarcinoma. Carbohydrate antigen 19–9 (CA 19–9) is a tumor marker only …

Somatic DNA mutations affecting the epidermal growth factor receptor (EGFR) signaling
pathway are known to predict responsiveness to EGFR-tyrosine kinase inhibitor drugs in …

CA 15‐3, CA 125 and β‐2 microglobulin are three common tumor markers currently used for
diagnosis, prognosis, assessment of therapeutic response, and/or to evaluate recurrence in …

Abstract Background In East Asia, the tumor infiltrative pattern (INF) has been routinely
evaluated by hematoxylin and eosin-stained sections as a pathologic characteristic of …

ABSTRACT Background Sinonasal inverted papillomas (IPs) can be associated
synchronously or metachronously to invasive squamous cell carcinoma (SCC) in 5% to 10 …

Immunohistochemical assessment of programmed cell death (PD)-ligand 1 (PD-L1)
expression in lung cancer in the context of therapeutically targeting the PD1/PD-L1 axis is …

The search for the genomic sequences involved in human cancers can be greatly facilitated
by maps of genomic imbalances identifying the involved chromosomal regions, particularly …

Abstract Background and Objectives The aim of this study was to evaluate the efficacy of
portal or superior mesenteric vein (PV/SMV) resection for patients with pancreatic carcinoma …

Background: BRAF mutations, the most common genetic alteration associated with papillary
thyroid carcinoma (PTC), have never been associated with follicular thyroid carcinoma (FTC) …

Introduction Galectin family members have been demonstrated to be abnormally expressed
in cancer at the protein and mRNA level. This study investigated the levels of galectin …